Basal GLP-1 levels in morbidly obese patients following biliopancreatic diversion surgery

Annals of Nutrition and Metabolism

Volumn 61, Issue 1, 2012, Pages 70-73

  De Luis, Daniel ^a   Pacheco, D ^a   Conde, Rosa ^a   Primo, David ^a   Aller, Rocio ^a   Izaola, Olatz ^a  

^a UNIVERSITY OF VALLADOLID   (Spain)

Author keywords

Biliopancreatic diversion; GLP 1; Morbid obesity; Surgery

Indexed keywords

GLUCAGON LIKE PEPTIDE 1; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ANTHROPOMETRIC PARAMETERS; ARTICLE; BARIATRIC SURGERY; BILIOPANCREATIC BYPASS; BODY FAT; BODY MASS; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CORRELATION ANALYSIS; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HUMAN; MALE; MORBID OBESITY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

ADULT; BILIOPANCREATIC DIVERSION; BLOOD GLUCOSE; BLOOD PRESSURE; BODY COMPOSITION; BODY MASS INDEX; CARDIOVASCULAR DISEASES; CHOLESTEROL, LDL; DIABETES MELLITUS; FEMALE; FOLLOW-UP STUDIES; GLUCAGON-LIKE PEPTIDE 1; HUMANS; MALE; MIDDLE AGED; OBESITY, MORBID; PROSPECTIVE STUDIES; RISK FACTORS; TRIGLYCERIDES; WAIST CIRCUMFERENCE; WEIGHT LOSS;

EID: 84864224068     PISSN: 02506807     EISSN: 14219697     Source Type: Journal    
DOI: 10.1159/000339378     Document Type: Article

References (20)

1. Sjostrom L, Lindroos AK, Peltonen M, et al: Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med 2004; 351: 2683-2693.
2. de Luis DA, Aller R, Izaola O, Pacheco D: Early clinical and surgical results of biliopancreatic diversion. Obes Surg 2005; 15: 799-802.
3. Scopinaro N, Gianetta E, Adami GF, et al: Biliopancreatic diversion for obesity at eighteen years. Surgery 1996; 119: 261-268.
4. Nauck MA: Glucagon-like peptide 1 (GLP-1): a potent gut hormone with a possible therapeutic perspective. Acta Diabetol 1998; 35: 117-129.
5. Brubaker PL, Drucker DJ: Minireview: glucagon-like peptides regulate cell proliferation and apoptosis in the pancreas, gut and central nervous system. Endocrinology 2004; 145: 2653-2659.
6. Valverde I, Villanueva-Peñacarrillo ML, Malaisse WJ: Pancreatic and extrapancreatic effects of GLP-1. Diabetes Metab 2002; 28: 3S85-3S89.
7. Sarson DL, Scopinaro N, Bloom SR: Gut hormone changes after jejunoileal (JIB) or biliopancreatic (BPB) bypass surgery for morbid obesity. Int J Obes 1981; 5: 471-480.
8. Lugari R, Dei Cas A, Ugolotti D, et al: Glucagon-like peptide 1 (GLP-1) secretion and plasma dipeptidyl peptidase IV (DPP-IV) activity in morbidly obese patients undergoing biliopancreatic diversion. Horm Metab Res 2004; 36: 111-115.
9. Scopinaro N, Adami GF, Marinari GM: Biliopancreatic diversion. World J Surg 1998; 22: 936-946.
10. American Diabetes Association: Standards of medical care in diabetes. Diabetes Care 2007; 30:s4-s41.
11. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP): Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001; 285: 2486-2487.
12. Rubino F: is type 2 diabetes an operable intestinal disease? A provocative yet reasonable hypothesis. Diabetes Care 2008: 31:s290-s296.
13. Kreymann B, Williams G, Ghatei MA, Bloom SR: Glucagon-like peptide-1 7-36: a physiological incretin in man. Lancet 1987; 2: 1300-1304.
14. Gutzwiller JP, Drewe J, Goke B, et al: Glucagon-like peptide-1 promotes satiety and reduces food intake in patients with diabetes mellitus type 2. Am J Physiol 1999; 276:R1541-R1544.
15. Farilla L, Bulotta A, Hirshberg B, et al: Glucagon-like peptide 1 inhibits cell apoptosis and improves glucose responsiveness of freshly isolated human islets. Endocrinology 2003; 144: 5149-5158.
16. Pories WJ, Swanson MS, MacDonald KG, et al: Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg 1995; 222: 339-350.
17. Valverde I, Puente J, Martin A, Dice A, Molina L, Lozano O: Changes in GLP-1 secretion after BPD or vertical banded gastroplasty in obese subjects. Obes Surg 2005; 15: 387-397.
18. Borg C, Roux C, Ghatel A, Bloom S, Patel A: BPD in rats is associated with intestinal hypertrophy and with increased GLP-1, GLP-2 and PYY. Obes Sur 2007; 17: 1193-1195.
19. Pacheco D, de Luis DA, Romero A, Gonzalez Sagrado M, Conde R, Izaola O: The effects of duodenal jejunal exclusion on hormonal regulation of glucose metabolism in Goto Kakizaki rats. Am J Surg 2007; 194: 221-224.
20. Yamaoka Tojo M, Tojo T, Takahira N, Matsunaga A, Aoyama A, Masuda T: Elevated circulating levels of an incretin hormone, GLP-1, are associated with metabolic components in high-risk patients with cardiovascular disease. Cardiovasc Diabetol 2010; 9: 17-21.